Erytech Pharma S.A. ERYTECH Provides Business Update and Reports Financial Results for Full Year 2018

Erytech Pharma S.A.: ERYTECH Provides Business Update and Reports Financial Results for Full Year 2018

Conference call and webcast on Tuesday, March 12th at 1:30 pm CET/8:30 am EDT TRYbeCA1, a pivotal Phase 3 trial for eryaspase in second line pancreatic cancer, now actively enrolling patientsTRYbeC...

More From BioPortfolio on "Erytech Pharma S.A.: ERYTECH Provides Business Update and Reports Financial Results for Full Year 2018"